alpha-methyl-4-carboxyphenylglycine has been researched along with bromodeoxyuridine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Ding, S; Li, H; Sun, G; Zhang, N | 1 |
2 other study(ies) available for alpha-methyl-4-carboxyphenylglycine and bromodeoxyuridine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Inhibition of the group I mGluRs reduces acute brain damage and improves long-term histological outcomes after photothrombosis-induced ischaemia.
Topics: Animals; Antimetabolites, Antineoplastic; Astrocytes; Benzoates; Blotting, Western; Brain; Brain Ischemia; Bromodeoxyuridine; Cell Death; Cell Proliferation; Cerebral Infarction; Excitatory Amino Acid Antagonists; Glycine; Immunohistochemistry; In Situ Nick-End Labeling; Intracranial Thrombosis; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neuroglia; Pyridines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate | 2013 |